Gases for Pharmaceutical and Biotechnology Industry Research Report 2024

Gases for Pharmaceutical and Biotechnology Industry Research Report 2024


Summary

According to APO Research, The global Gases for Pharmaceutical and Biotechnology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Gases for Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Gases for Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Gases for Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Gases for Pharmaceutical and Biotechnology include etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gases for Pharmaceutical and Biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gases for Pharmaceutical and Biotechnology.

The report will help the Gases for Pharmaceutical and Biotechnology manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Gases for Pharmaceutical and Biotechnology market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gases for Pharmaceutical and Biotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Air Liquide
Taiyo Nippon Sanso
Messer Group
Matheson
Air Products
Coregas
Linde
SOL Group
Gases for Pharmaceutical and Biotechnology segment by Type

Nitrogen
Carbon Dioxide
Oxygen
Others
Gases for Pharmaceutical and Biotechnology segment by Application

Laboratory
Pharmaceutical and Biotechnology Companies
Others
Gases for Pharmaceutical and Biotechnology Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gases for Pharmaceutical and Biotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gases for Pharmaceutical and Biotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gases for Pharmaceutical and Biotechnology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Gases for Pharmaceutical and Biotechnology manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Gases for Pharmaceutical and Biotechnology by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Gases for Pharmaceutical and Biotechnology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Gases for Pharmaceutical and Biotechnology by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.2.2 Nitrogen
2.2.3 Carbon Dioxide
2.2.4 Oxygen
2.2.5 Others
2.3 Gases for Pharmaceutical and Biotechnology by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Laboratory
2.3.3 Pharmaceutical and Biotechnology Companies
2.3.4 Others
2.4 Global Market Growth Prospects
2.4.1 Global Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts (2019-2030)
2.4.2 Global Gases for Pharmaceutical and Biotechnology Production Capacity Estimates and Forecasts (2019-2030)
2.4.3 Global Gases for Pharmaceutical and Biotechnology Production Estimates and Forecasts (2019-2030)
2.4.4 Global Gases for Pharmaceutical and Biotechnology Market Average Price (2019-2030)
3 Market Competitive Landscape by Manufacturers
3.1 Global Gases for Pharmaceutical and Biotechnology Production by Manufacturers (2019-2024)
3.2 Global Gases for Pharmaceutical and Biotechnology Production Value by Manufacturers (2019-2024)
3.3 Global Gases for Pharmaceutical and Biotechnology Average Price by Manufacturers (2019-2024)
3.4 Global Gases for Pharmaceutical and Biotechnology Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Gases for Pharmaceutical and Biotechnology Key Manufacturers, Manufacturing Sites & Headquarters
3.6 Global Gases for Pharmaceutical and Biotechnology Manufacturers, Product Type & Application
3.7 Global Gases for Pharmaceutical and Biotechnology Manufacturers, Date of Enter into This Industry
3.8 Global Gases for Pharmaceutical and Biotechnology Market CR5 and HHI
3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Air Liquide
4.1.1 Air Liquide Gases for Pharmaceutical and Biotechnology Company Information
4.1.2 Air Liquide Gases for Pharmaceutical and Biotechnology Business Overview
4.1.3 Air Liquide Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2019-2024)
4.1.4 Air Liquide Product Portfolio
4.1.5 Air Liquide Recent Developments
4.2 Taiyo Nippon Sanso
4.2.1 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Company Information
4.2.2 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Business Overview
4.2.3 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2019-2024)
4.2.4 Taiyo Nippon Sanso Product Portfolio
4.2.5 Taiyo Nippon Sanso Recent Developments
4.3 Messer Group
4.3.1 Messer Group Gases for Pharmaceutical and Biotechnology Company Information
4.3.2 Messer Group Gases for Pharmaceutical and Biotechnology Business Overview
4.3.3 Messer Group Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2019-2024)
4.3.4 Messer Group Product Portfolio
4.3.5 Messer Group Recent Developments
4.4 Matheson
4.4.1 Matheson Gases for Pharmaceutical and Biotechnology Company Information
4.4.2 Matheson Gases for Pharmaceutical and Biotechnology Business Overview
4.4.3 Matheson Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2019-2024)
4.4.4 Matheson Product Portfolio
4.4.5 Matheson Recent Developments
4.5 Air Products
4.5.1 Air Products Gases for Pharmaceutical and Biotechnology Company Information
4.5.2 Air Products Gases for Pharmaceutical and Biotechnology Business Overview
4.5.3 Air Products Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2019-2024)
4.5.4 Air Products Product Portfolio
4.5.5 Air Products Recent Developments
4.6 Coregas
4.6.1 Coregas Gases for Pharmaceutical and Biotechnology Company Information
4.6.2 Coregas Gases for Pharmaceutical and Biotechnology Business Overview
4.6.3 Coregas Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2019-2024)
4.6.4 Coregas Product Portfolio
4.6.5 Coregas Recent Developments
4.7 Linde
4.7.1 Linde Gases for Pharmaceutical and Biotechnology Company Information
4.7.2 Linde Gases for Pharmaceutical and Biotechnology Business Overview
4.7.3 Linde Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2019-2024)
4.7.4 Linde Product Portfolio
4.7.5 Linde Recent Developments
4.8 SOL Group
4.8.1 SOL Group Gases for Pharmaceutical and Biotechnology Company Information
4.8.2 SOL Group Gases for Pharmaceutical and Biotechnology Business Overview
4.8.3 SOL Group Gases for Pharmaceutical and Biotechnology Production Capacity, Value and Gross Margin (2019-2024)
4.8.4 SOL Group Product Portfolio
4.8.5 SOL Group Recent Developments
5 Global Gases for Pharmaceutical and Biotechnology Production by Region
5.1 Global Gases for Pharmaceutical and Biotechnology Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
5.2 Global Gases for Pharmaceutical and Biotechnology Production by Region: 2019-2030
5.2.1 Global Gases for Pharmaceutical and Biotechnology Production by Region: 2019-2024
5.2.2 Global Gases for Pharmaceutical and Biotechnology Production Forecast by Region (2025-2030)
5.3 Global Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
5.4 Global Gases for Pharmaceutical and Biotechnology Production Value by Region: 2019-2030
5.4.1 Global Gases for Pharmaceutical and Biotechnology Production Value by Region: 2019-2024
5.4.2 Global Gases for Pharmaceutical and Biotechnology Production Value Forecast by Region (2025-2030)
5.5 Global Gases for Pharmaceutical and Biotechnology Market Price Analysis by Region (2019-2024)
5.6 Global Gases for Pharmaceutical and Biotechnology Production and Value, YOY Growth
5.6.1 North America Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts (2019-2030)
5.6.2 Europe Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts (2019-2030)
5.6.3 China Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts (2019-2030)
5.6.4 Japan Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts (2019-2030)
6 Global Gases for Pharmaceutical and Biotechnology Consumption by Region
6.1 Global Gases for Pharmaceutical and Biotechnology Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
6.2 Global Gases for Pharmaceutical and Biotechnology Consumption by Region (2019-2030)
6.2.1 Global Gases for Pharmaceutical and Biotechnology Consumption by Region: 2019-2030
6.2.2 Global Gases for Pharmaceutical and Biotechnology Forecasted Consumption by Region (2025-2030)
6.3 North America
6.3.1 North America Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Gases for Pharmaceutical and Biotechnology Consumption by Country (2019-2030)
6.3.3 United States
6.3.4 Canada
6.4 Europe
6.4.1 Europe Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Gases for Pharmaceutical and Biotechnology Consumption by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Gases for Pharmaceutical and Biotechnology Consumption by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 China Taiwan
6.5.7 Southeast Asia
6.5.8 India
6.5.9 Australia
6.6 Latin America, Middle East & Africa
6.6.1 Latin America, Middle East & Africa Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 Latin America, Middle East & Africa Gases for Pharmaceutical and Biotechnology Consumption by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.5 GCC Countries
7 Segment by Type
7.1 Global Gases for Pharmaceutical and Biotechnology Production by Type (2019-2030)
7.1.1 Global Gases for Pharmaceutical and Biotechnology Production by Type (2019-2030) & (Tons)
7.1.2 Global Gases for Pharmaceutical and Biotechnology Production Market Share by Type (2019-2030)
7.2 Global Gases for Pharmaceutical and Biotechnology Production Value by Type (2019-2030)
7.2.1 Global Gases for Pharmaceutical and Biotechnology Production Value by Type (2019-2030) & (US$ Million)
7.2.2 Global Gases for Pharmaceutical and Biotechnology Production Value Market Share by Type (2019-2030)
7.3 Global Gases for Pharmaceutical and Biotechnology Price by Type (2019-2030)
8 Segment by Application
8.1 Global Gases for Pharmaceutical and Biotechnology Production by Application (2019-2030)
8.1.1 Global Gases for Pharmaceutical and Biotechnology Production by Application (2019-2030) & (Tons)
8.1.2 Global Gases for Pharmaceutical and Biotechnology Production by Application (2019-2030) & (Tons)
8.2 Global Gases for Pharmaceutical and Biotechnology Production Value by Application (2019-2030)
8.2.1 Global Gases for Pharmaceutical and Biotechnology Production Value by Application (2019-2030) & (US$ Million)
8.2.2 Global Gases for Pharmaceutical and Biotechnology Production Value Market Share by Application (2019-2030)
8.3 Global Gases for Pharmaceutical and Biotechnology Price by Application (2019-2030)
9 Value Chain and Sales Channels Analysis of the Market
9.1 Gases for Pharmaceutical and Biotechnology Value Chain Analysis
9.1.1 Gases for Pharmaceutical and Biotechnology Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Gases for Pharmaceutical and Biotechnology Production Mode & Process
9.2 Gases for Pharmaceutical and Biotechnology Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Gases for Pharmaceutical and Biotechnology Distributors
9.2.3 Gases for Pharmaceutical and Biotechnology Customers
10 Global Gases for Pharmaceutical and Biotechnology Analyzing Market Dynamics
10.1 Gases for Pharmaceutical and Biotechnology Industry Trends
10.2 Gases for Pharmaceutical and Biotechnology Industry Drivers
10.3 Gases for Pharmaceutical and Biotechnology Industry Opportunities and Challenges
10.4 Gases for Pharmaceutical and Biotechnology Industry Restraints
11 Report Conclusion
12 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings